D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease - Wikidata - wikimedia - TriplyDB

D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease

D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease

http://www.wikidata.org/entity/Q36976707

about

The ketogenic diet as a treatment paradigm for diverse neurological disorders Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial Hypometabolism as a therapeutic target in Alzheimer's disease A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis Ketogenic diet in neuromuscular and neurodegenerative diseases Targeting energy metabolism in brain cancer: review and hypothesis The ketogenic diet: uses in epilepsy and other neurologic illnesses The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies Neuroprotective and disease-modifying effects of the ketogenic diet Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake Calorie restriction extends life span--but which calories?Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate Ketogenic diet improves forelimb motor function after spinal cord injury in rodents Ketones prevent oxidative impairment of hippocampal synaptic integrity through KATP channels Enatiomerically pure hydroxycarboxylic acids: current approaches and future perspectives A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans.Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease.Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury.Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure Upon Pparα Deficiency Nutritional Ketosis Affects Metabolism and Behavior in Sprague-Dawley Rats in Both Control and Chronic Stress Environments.Differential Fasting Plasma Glucose and Ketone Body Levels in GHRKO versus 3xTg-AD Mice: A Potential Contributor to Aging-Related Cognitive Status?Cerebral metabolic adaptation and ketone metabolism after brain injury.Natural products and supplements for geriatric depression and cognitive disorders: an evaluation of the research.D-β-hydroxybutyrate is protective in mouse models of Huntington's disease.A ketone ester diet increases brain malonyl-CoA and Uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar Rat.How wasting is saving: weight loss at altitude might result from an evolutionary adaptation.Geniposide, the component of the Chinese herbal formula Tongluojiunao, protects amyloid-β peptide (1-42-mediated death of hippocampal neurons via the non-classical estrogen signaling pathway.Ketoacids? Good medicine?D-beta-hydroxybutyrate extends lifespan in C. elegans.Ketone ester effects on metabolism and transcription.Ketone bodies as signaling metabolites.Neuroprotection by acetoacetate and β-hydroxybutyrate against NMDA-induced RGC damage in rat--possible involvement of kynurenic acid Fasting mitigates immediate hypersensitivity: a pivotal role of endogenous D-beta-hydroxybutyrate.Characterization of medium chain length (R)-3-hydroxycarboxylic acids produced by Streptomyces sp. JM3 and the evaluation of their antimicrobial properties.Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets.Upregulation of GPR109A in Parkinson's disease

P2860

Q21129287-80FDA159-DCDA-43C3-92A5-78ABC3CC42E9 Q21245063-06E2D980-B804-4322-BD19-88D9A74B138E Q21262020-6D1F3ED6-2CC4-4DBE-9144-8D1211E0DA3C Q21262053-13FE74AC-044B-4FE3-98E6-D7EA0CAB682C Q21284703-7180428C-657D-412E-B25E-80C40060EC98 Q24537119-B49A63C6-E7E0-4AE5-9B05-287E95AF14CF Q24617926-ADDF5255-19D3-4EAD-B5D4-BA445007C334 Q24646616-1F0674D5-09E5-4480-8240-50A5C5F70B81 Q24646914-39DD2071-9796-4E40-98CC-2FA28A52AE6F Q24674863-D8F016C5-961D-4586-A4A8-D5155361C6D5 Q24816934-D2F3418F-3E4B-41D2-8BC0-07AAD227FC1E Q26382049-F960B0C1-4282-4EED-AC83-B4C9117F100E Q26769966-DA124D0C-8A48-4990-AF57-A0CCC13AC10D Q26828498-483B302E-FFF6-4B7D-BA59-665ECC56B6C2 Q28276049-375C5D88-565D-4A65-A4CD-BBCB5AA1861B Q28534800-8BA114A9-8415-424A-A566-A28C95AD05DA Q28545771-11BC2A69-83F7-4611-AACC-B33C9CE76EBA Q28752123-6F15EC40-DCE8-46BC-B4AD-9BF48A47C10B Q30538459-A9CAD652-53C4-4855-84A8-0851FDC02D1B Q33225632-1C8F4766-0E48-4413-8C3A-035B3AD7D2F3 Q33460503-883D74F3-CE7F-491D-9D0C-E6F3D8D45FE7 Q33563284-230F19AD-3172-4263-818F-619BEE6BDF27 Q33631584-6353F6FD-1C55-47B4-BE44-F4B1CEB95F7C Q33679293-C2589912-24B8-40D3-99D8-32029D9B011D Q33790607-9C5603EF-808E-4DE2-BEDC-30618041AF3F Q33802454-66030132-0796-49B0-AF28-2B09DFAE7F3B Q33946426-D0B960ED-805B-47FA-BB26-13367246646B Q34023773-D48A1FEF-2DEB-474F-9C3F-CC37318CCAA7 Q34074233-5128581A-2750-4B3E-8E81-04C14C7D8D93 Q34086586-36F9DC84-54C5-4AF4-BEF9-B2D7F5FE6D37 Q34128104-D54AACA7-17FC-4B14-9C00-58A9A95090EC Q34206876-2F0CF9D0-AAAB-4F4B-AA0B-68594B4D8ECE Q34217599-5A3098CB-3ABD-431F-96EB-7B939741E804 Q34238624-03C68C80-A653-4E7B-8EA0-BB3B7D9297AE Q34252732-6705EFA4-C4A5-421F-A30A-4B3723C25EEB Q34280603-6DA3887A-7829-452C-B25C-FCC4400A06E4 Q34311337-4784C71F-5F80-49F8-A0D7-C5CF9F3E477D Q34340889-75412609-1FF5-4F90-BAAA-EF62C10679C1 Q34353543-A68B54E9-A3F1-4C9E-974B-D322E7C6FAF4 Q34361793-7BFAF6E7-4C08-4F27-BE7B-8371E4CF8F47

P2860

D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease

http://www.wikidata.org/entity/Q36976707

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease

@en

type

label

D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease

@en

altLabel

D-beta -Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease

@en

prefLabel

D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease

@en

P1433

Q36976707-3A4A1276-43E7-4400-8494-BF9393A0AA60

P1476

Q36976707-2132F74C-6F87-4ADB-858A-89B0993B9A27

P2093

Q36976707-1063F05F-64D6-4273-9CFB-F67C5AF8D05E

Q36976707-1386C493-F6D6-44DB-B9BB-3532F126947F

Q36976707-43E8DE2B-5861-40D5-8A58-A3D2BD58B224

Q36976707-5DB69F3C-0445-4FFB-B190-8C4C5D4AD527

Q36976707-AD250C6F-EE8B-4405-BB9E-C4318089B01D

Q36976707-D8A55175-0F29-46B0-852C-284942D5E649

P2860

Q36976707-01FAC8F6-7A1B-43E7-9E5D-D0BD0D94B09D

Q36976707-040A4DE5-C025-4C58-81C2-92176DCF5C01

Q36976707-0ECB3FAF-5600-4515-B7C9-CD8EC98F17A2

Q36976707-161207B0-A51B-4938-BFC1-D8DD532030CA

Q36976707-17DFC921-4F8B-4D31-82C4-01E3717DACE4

Q36976707-31072943-AAAE-45E6-8367-95E81DDD74E0

Q36976707-38697C97-162E-48C2-81D7-99BE1604787A

Q36976707-41CF0303-69AD-45DF-B2D6-27E680A0597F

Q36976707-49E20A65-3163-46B6-B732-BA4A2A315C8B

Q36976707-584C722C-D075-4075-828E-813781E6901F

P304

Q36976707-292CA9F5-14CD-46C9-BC36-8104D04D4F03

P31

Q36976707-7E698A2C-5C10-4021-8E16-48C4A172EF55

P356

Q36976707-7CE333A5-5DAA-41DB-9CDA-57E0905AA7B3

P407

Q36976707-593AC0F3-857D-4105-9A5A-6EB45D9DDD2E

P433

Q36976707-434323F0-F721-4F6B-BD41-1DB389F30325

P478

Q36976707-169A7B1B-6F2B-447C-924D-7EC384A8BBCC

P577

Q36976707-3EDD738D-655C-4235-9E80-49936E904F3A

P5875

Q36976707-2C9FDA51-4957-4998-87A8-B8F05E145EE8

P698

Q36976707-03EE0AF1-91D1-403A-89AA-E79E0BCC68EB

P921

Q36976707-63B631F4-B1B0-4C30-9CBD-187E4F2AFC16

Q36976707-FC38CA65-2834-4069-8FE3-8CC9B617ED5C

P932

Q36976707-16CD51F2-4DE9-4E9D-B479-B61E22B9A67B

P356

PNAS.97.10.5440

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease

@en

P2093

K Clarke

http://www.w3.org/2001/XMLSchema#string

K Nakashima

http://www.w3.org/2001/XMLSchema#string

N Mori

http://www.w3.org/2001/XMLSchema#string

R L Veech

http://www.w3.org/2001/XMLSchema#string

T Takeshima

http://www.w3.org/2001/XMLSchema#string

Y Kashiwaya

http://www.w3.org/2001/XMLSchema#string

P2860

Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

Can biotechnology move us toward a sustainable society?

Prospects for new restorative and neuroprotective treatments in Parkinson's disease

Control of glucose utilization in working perfused rat heart

Alzheimer's disease: the amyloid cascade hypothesis

Hydroperoxide metabolism in mammalian organs

Mitochondrial diseases in man and mouse

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

New order from neurological disorders.

P304

5440-5444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.97.10.5440

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2000-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235613934

http://www.w3.org/2001/XMLSchema#string

P698

10805800

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Parkinson's disease

P932

25847

http://www.w3.org/2001/XMLSchema#string